Products |

CardioPerfect Workstation Version 1.6.4

Related Content

orchestration, cardiology suite, inflo
News | Cardiac Diagnostics
Inflo Health Launches New Cardiology Suite

March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps ...

Home March 04, 2026
Home
rural healthcare, cardiac assessment, stethoscope
News | Cardiac Diagnostics
Mississippi Hospital, Eko Health Partner to Deploy AI-Assisted Cardiac Detection in Rural Locations

Feb. 26, 2026 — Eko Health has partnered with Wayne General Hospital in Wayne County, Mississippi, to deploy SENSORA, an ...

Home February 26, 2026
Home
Africa initiative offers blueprint for U.S. cardiology deserts where FDA-cleared AI platform puts specialist-level cardiac diagnosis in the hands of any bedside clinician.
News | Cardiac Diagnostics
AISAP Develops AI-Powered Cardiac Diagnosis Platform That Offers Blueprint for U.S. Cardiology Deserts

Nov. 12, 2025 — AISAP, a provider of AI Point-of-Care Diagnostics, has announced a field initiative in Ghana, deploying ...

Home November 12, 2025
Home
SmartVascular Test Enhances Vascular Risk Assessment
News | Cardiac Diagnostics
SmartVascular Test Helps Improve Vascular Risk Assessment

June 11, 2025 — MorningStar Laboratories, LLC, a developer of precision diagnostic tests that address unmet clinical ...

Home June 16, 2025
Home
Ann Marie Navar, M.D., Ph.D.
News | Cardiac Diagnostics
Researchers Find ApoB Test May be More Accurate Measure of Heart Disease Risk

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil
Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics
Wireless Handheld Ultrasound Device Launched by GE HealthCare for Rapid Assessment of Cardiac and Vascular Patients

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 billion by 2026. With a CAGR of 14.4% over the forecast period
Feature | Cardiac Diagnostics | By Kelly Patrick
Ambulatory Diagnostic Cardiology Market to Hit $3.3 Billion by 2026

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD, have been reported by G3 Therapeutics (Global Genomics Group) and Aitia.
News | Cardiac Diagnostics
Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital health company designed the app to support researchers and advance the adoption of digital health technology in cardiac practice.
News | Cardiac Diagnostics
European digital health company launches app to support cardiac health

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now